Zn-Phthalocyanine as a Possible Phototherapeutic Agent for Tumours

  • R. Biolo
  • E. Menegaldo
Conference paper
Part of the NATO ASI Series book series (volume 15)


The use of phthalocyanines as photosensitizers in the photodynamic therapy (PDT) of tumours is raising the interest of several research and clinical groups because of the large potential advantages of these dyes. In particular, phthalocyanines are better tumour-photosensitizers than many porphyrins (1). We are using Zn(II)-phthalocyanine (Zn-Pc), which has a high degree of purity and can be readily incorporated into small unilamellarliposomes of dipalmitoyl-phosphatidylcholine (DPPC) (2). Preliminary PDT studies performed by injecting Balb/c mice bearing a transplanted MS-2 fibrosarcoma with 0.5 mg/kg Zn-Pc showed that an extensive necrosis of the tumour tissue can be obtained by irradiation with ca. 660 nm-light (total 2 2 light dose: 300 J/cm2; dose-rate: 270–370 mW/cm2). Therefore, it appears of interest to investigate the detailed aspects of the mechanisms by which Zn-Pc is accumulated and retained by tumours and, once photoactivated, causes the necrosis of the tumour tissue. In this paper, we report some pharmacokinetic and ultrastructural studies with Zn-Pc in vivo.


Photodynamic Therapy Light Dose Protein Class Extensive Necrosis Detailed Aspect 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ben-Hur E, Rosenthal J (1985) The phthalocyanines: a new class of manmalian cells photosensitizers with a potential for cancer phototherapy. Int J Radiat Biol 47: 145–151CrossRefGoogle Scholar
  2. 2.
    Valduga G, Reddi E, Jori G (1987) Spectroscopic studies on Zn(II)-phthalocyanine in homogeneous and microheterogeneous systems. J Inorg Biochem 29: 59–65CrossRefGoogle Scholar
  3. 3.
    Barel A, Beltramini M, Garbo G.M, Perin A, Reddi E, Romandini P, Jori G (1985) In vitro and in vivo studies on the mechanisms of porphyrin photosensitization of tumour cells. Med Biol Environ 13: 17–23Google Scholar
  4. 4.
    Jori G, Beltramini M, Reddi E, Salvato B, Pagnan A, Ziron L, Tornio L, Tsanov T (1984) Evidence for a major role of plasma lipoproteins as hematoporphyrin carriers in vivo. Cancer Lett 24: 291–297CrossRefGoogle Scholar
  5. 5.
    Dougherty T.J (1984) An overview of the status of photoradiation therapy. In: Doiron D, Gomer C.J (eds) Porphyrin Localization and Treatment of Tumours. Plenum Publishing Co, New York, pp l57–165Google Scholar
  6. 6.
    Milanesi C, Biolo R, Reddi E, Jori G (1987) Ultrastructural studies on the mechanism of the photodynamic therapy of tumours. Photochem Photobiol, in the pressGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • R. Biolo
    • 1
  • E. Menegaldo
    • 1
  1. 1.Department of BiologyUniversity of PadovaPadovaItaly

Personalised recommendations